Market – Page 11

Ono Pharmaceutical Strengthens Oncology Portfolio with Acquisition of Deciphera Pharmaceuticals for $2.4 Billion

2 years ago talkbio0Tagged Acquisition (action), cancer treatments, Clinical Development, Collaboration, Deciphera, Dosage Forms, expansion, Generalized, Market, Oncology Pipeline, strategic

Ono Pharmaceutical, Deciphera Pharmaceuticals, oncology pipeline, acquisition, $2.4 billion, cancer treatments, kinase inhibitors, strategic expansion, global market, clinical development, collaboration.

FDA Approves Long-Established European UTI Antibiotic by Utility Therapeutics

2 years ago talkbio0Tagged Antibiotics, European (ethnic group), Market, United States Food and Drug Administration, Urinary tract infection, UTI, year

Utility Therapeutics, FDA, UTI antibiotic, European market, 40-plus years.

Strategic Acquisition, Partnership, and Development of Innovative Assets in Biopharma

2 years ago talkbio0Tagged Acquisition (action), Biopharma, development aspects, Drug Development, Drug Industry, innovative assets, Market, Partnership, Portfolio diversification, Risk Management, strategic decision-making, trends qualifier

Biopharma, Innovative Assets, Acquisition, Partnership, Development, Strategic Decision-Making, Pharmaceutical Industry, Drug Development, Market Trends, Risk Management, Portfolio Diversification

Biogen’s Leqembi Gains Momentum: A Steady Pace in Market Growth

2 years ago talkbio0Tagged Alzheimer 's disease, Approved, Biogen, Clinical Trials, Growth, Health care facility, Leqembi, Market, Neurology speciality, United States Food and Drug Administration

Biogen, Leqembi, Alzheimer’s disease, clinical trials, FDA approval, market growth, steady pace, neurology, healthcare, pharmaceuticals.

Projected $270 Billion Orphan Drug Market by 2028: A Comprehensive Analysis of Leading Players J&J, Vertex, and Roche

2 years ago talkbio0Tagged Drugs, Orphan, Evaluation, Growth, J&J, Market, Roche (company)

Orphan drugs, rare diseases, J&J, Vertex, Roche, market growth, 2028, Evaluate

AbbVie Emerges as Leading Immunology Company in Doctor Rankings, Surpassing Pfizer and Johnson & Johnson

2 years ago talkbio0Tagged AbbVie, Drug Industry, Immunology, Johnson & Johnson, Market, Performance, Pfizer, Physicians, portfolio, product, reputation

AbbVie, Pfizer, Johnson & Johnson, doctor ranking, immunology companies, pharmaceutical industry, market performance, reputation, product portfolio.

CSL Vifor’s Corrective Marketing Initiative to Address Anti-Competitive Concerns

2 years ago talkbio0Tagged anti-competitive practices, competition, Corrective, CSHL1 gene, Drug Industry, fairness, Market, Measures, Vifor

CSL Vifor, marketing campaign, anti-competitive practices, competition law, corrective measures, pharmaceutical industry, competition watchdog, market fairness.

Sanofi Restructures US Commercial Vaccine Group Amid Cost-Saving Campaign

2 years ago talkbio0Tagged Commercial Vaccine, Cost-Savings Campaign, Effectiveness, Efficiency, Employee, Evolving, Market, Optimization, Outplacement, restructuring, sanofi, streamlined strategic sales, Structure, Vaccines

Sanofi, Restructuring, US Commercial Vaccine Group, Cost-Savings Campaign, Streamlined Strategic Sales Structure, Evolving Vaccine Market, Optimization for Efficiency and Effectiveness, Employee Support and Outplacement Assistance